December 15th, 2015

Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen experimental drug shows evidence of optic nerve repair

[Reuters] – An experimental drug from Biogen Idec Inc showed evidence of biological repair of the optic nerve in a mid-stage study in patients with acute optic neuritis, an inflammation of the optic . . . → Read More: Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen experimental drug shows evidence of optic nerve repair Similar Articles: Market Update (NASDAQ:BIIB): Biogen Idec to Present Data from Hematology Programs, Including ELOCTATE™ and ALPROLIX® at ASH Annual Meeting Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub Market Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen wins U.S. approval of long acting multiple sclerosis drug
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.